161 related articles for article (PubMed ID: 11128112)
1. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery.
Tamir L; Fradin Z; Fridlander M; Ashkenazi U; Zeidman A; Cohen AM; Hendel D; Mittelman M
Haematologia (Budap); 2000; 30(3):193-201. PubMed ID: 11128112
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
5. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.
Martino M; Oliva E; Console G; Stelitano C; Fujo M; Messina G; Irrera G; Pucci G; Mandaglio R; Callea V; Nobile F; Iacopino P; Morabito F
Support Care Cancer; 2005 Mar; 13(3):182-7. PubMed ID: 15480819
[TBL] [Abstract][Full Text] [Related]
6. The effect of erythropoietin on allogeneic blood requirement in patients undergoing elective liver resection: a model simulation.
Lentschener C; Gomola A; Grabar S; Soubrane O; Dousset B; Massault PP; Penhoud C; Ozier Y
Anesth Analg; 2004 Apr; 98(4):921-926. PubMed ID: 15041573
[TBL] [Abstract][Full Text] [Related]
7. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
Matsui H; Shiraishi N; Yasuda T; Nezuka T
Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
[TBL] [Abstract][Full Text] [Related]
8. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
García-Erce JA; Cuenca J; Haman-Alcober S; Martínez AA; Herrera A; Muñoz M
Vox Sang; 2009 Oct; 97(3):260-7. PubMed ID: 19497085
[TBL] [Abstract][Full Text] [Related]
13. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
[TBL] [Abstract][Full Text] [Related]
14. [Case-control study on the efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in elderly patients undergoing elective surgery for femoral intertrochanteric fractures].
Xie B; Tian J; Yang C; Zhou DP; Xiang LB
Zhongguo Gu Shang; 2015 Jul; 28(7):633-7. PubMed ID: 26399106
[TBL] [Abstract][Full Text] [Related]
15. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement.
Gombotz H; Gries M; Sipurzynski S; Fruhwald S; Rehak P
Acta Anaesthesiol Scand; 2000 Jul; 44(6):737-42. PubMed ID: 10903019
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
[TBL] [Abstract][Full Text] [Related]
17. A protocol avoiding allogeneic transfusion in joint arthroplasties.
Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
[TBL] [Abstract][Full Text] [Related]
18. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial.
Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
Transfusion; 1996 Jan; 36(1):29-36. PubMed ID: 8607150
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
[TBL] [Abstract][Full Text] [Related]
20. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
